A detailed history of Cetera Investment Advisers transactions in Altimmune, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 13,083 shares of ALT stock, worth $105,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,083
Previous 13,032 0.39%
Holding current value
$105,318
Previous $86,000 6.98%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.5 - $8.1 $280 - $413
51 Added 0.39%
13,083 $80,000
Q2 2024

Aug 22, 2024

SELL
$5.91 - $10.23 $309,116 - $535,069
-52,304 Reduced 80.05%
13,032 $86,000
Q1 2024

May 24, 2024

BUY
$8.22 - $13.81 $537,061 - $902,290
65,336 New
65,336 $665,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $395M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.